Latest New Zealand Market News

Delorean Corporation has transitioned to the operations and maintenance phase at its $53 million Yarra Valley Water bioenergy facility, marking a key milestone in its renewable energy expansion.

Amotiv Limited reported steady FY25 financials with marginal revenue growth and a slight EBITA dip, while unveiling its ambitious Amotiv2030 strategy to drive future shareholder value amid ongoing market challenges.

EVT Limited reports a robust 20.7% rise in Q1 EBITDA, driven by all divisions, with Hotels leading record results and a strategic acquisition poised to boost earnings further.

Michael Hill International reported steady FY25 financials amid challenging markets, with early FY26 trading showing promising margin improvements and mixed sales across regions.

Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.

Tower Limited has raised its full-year profit guidance significantly, driven by lower-than-expected large event costs, even as it moderates its premium growth outlook.

Biome Australia has partnered with Green Cross Health to launch its Activated Probiotics across New Zealand’s largest pharmacy network, marking a pivotal step in its international growth strategy.

RMA Global Ltd reported a 13% revenue increase to $21.1 million in FY25, driven by growth in the US and New Zealand, alongside steady Australian performance. The company also recorded its first full-year positive operating cash flow, marking a significant financial turnaround.

Shine Justice Ltd reported a 4.4% rise in FY25 revenue to $204.4 million, alongside major legal settlements and leadership changes, signaling renewed growth momentum.

Austco Healthcare Limited reported a record $81.4 million in revenue for FY25, driven by organic growth and acquisitions including G&S Technologies. EBITDA jumped 62% to $13 million, reflecting strong operational leverage.

Michael Hill International reported steady FY25 results with flat revenue and modest profit improvement amid challenging market conditions. The company is focusing on brand repositioning, operational efficiency, and AI innovation as it navigates a complex retail environment.

Michael Hill International reported broadly flat FY25 financial results despite challenging retail conditions, with growth in Australia and Canada offset by ongoing difficulties in New Zealand. Strategic initiatives and early FY26 sales hint at cautious optimism.